DIOPHAR IN €15 MILLION PHARMACEUTICALS DISPUTE

Posted on January 2014June 2021 by P&P

Papapolitis & Papapolitis acted for Diophar, a leading Greek pharmaceuticals company, in relation to a €15 Million dispute with Baxter International.

site by DIGITIFY - PREMIUM WEB SOLUTIONS

MENU

HOME
ABOUT
OUR PEOPLE
TRANSACTIONS
AWARDS
LATEST NEWS
CONTACT

SERVICES OVERVIEW
1. BANKING & FINANCE
2. CORPORATE AND M&A
3. CAPITAL MARKETS
4. FINANCIAL SERVICES REGULATION
5. FUNDS
6. ENERGY
7. REAL ESTATE
8. DISPUTE RESOLUTION
9. RESTRUCTURING

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.